SCHEMBL4358001

SCHEMBL4358001

O=Cc1cn(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c2ccccc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 12/20 0.64
▸ SMN1; SMN2 Q16637 11/20 0.64
▸ HTT P42858 9/20 0.64
▸ LMNA P02545 7/20 0.63
▸ TDP1 Q9NUW8 1/20 0.63
▸ KMT2A Q03164 6/20 0.55
▸ MAPT P10636 5/20 0.55
▸ MEN1 O00255 5/20 0.55
▸ PTGS2 P35354 1/20 0.54
▸ PARP1 P09874 1/20 0.53
▸ NPSR1 Q6W5P4 3/20 0.46
▸ HSP90AA1 P07900 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ NPC1 O15118 1/20 0.45
▸ HPGD P15428 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30379870 1.00 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL26552342 0.93 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL13621788 0.93 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL8686733 0.90 ALDH1A1 (0.71) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL5870668 0.88 ALDH1A1 (0.73) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL28238254 0.87 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL16071151 0.87 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL8685621 0.83 ADCYAP1R1 (0.47) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL28536460 0.81 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL30379002 0.80 SNCA (0.51) ALDH1A1SMN1; SMN2HTTLMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304579-A1 COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2025-10-02 — — US disclosed
US-12227503-B2 Compositions and methods for modulating hair growth THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-02-18 — — US disclosed
US-20240025895-A1 COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2024-01-25 — — US disclosed
US-20240025895-A1 COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2024-01-25 — — US disclosed
US-11787804-B2 Compositions and methods for modulating hair growth THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-17 — — US disclosed
US-11787804-B2 Compositions and methods for modulating hair growth THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-17 — — US disclosed
CN-116120314-A Compositions and methods for modulating hair growth 加利福尼亚大学董事会 2023-05-16 — — CN disclosed
US-20230114220-A1 COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-04-13 — — US disclosed
US-20230114220-A1 COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-04-13 — — US disclosed
US-11472804-B2 Compositions and methods for modulating hair growth THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-10-18 — — US disclosed
CN-110944634-A Compositions and methods for regulating hair growth 加利福尼亚大学董事会 2020-03-31 — — CN disclosed
WO-2019006359-A1 COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-01-03 — — WO disclosed
WO-2019006359-A1 COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-01-03 — — WO disclosed
US-8883841-B2 Oncogenic ras-specific cytotoxic compound and methods of use thereof THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-11-11 — — US disclosed
US-8883841-B2 Oncogenic ras-specific cytotoxic compound and methods of use thereof THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-11-11 — — US disclosed
EP-1956910-B1 ONCOGENIC RAS-SPECIFIC CYTOTOXIC COMPOUND AND METHODS OF USE THEREOF UNIV TEXAS (US) 2014-09-17 — — EP disclosed
US-20090286847-A1 ONCOGENIC RAS-SPECIFIC CYTOTOXIC COMPOUND AND METHODS OF USE THEREOF BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2009-11-19 — — US disclosed
US-20090286847-A1 ONCOGENIC RAS-SPECIFIC CYTOTOXIC COMPOUND AND METHODS OF USE THEREOF BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2009-11-19 — — US disclosed
EP-1956910-A2 ONCOGENIC RAS-SPECIFIC CYTOTOXIC COMPOUND AND METHODS OF USE THEREOF The Board of Regents of The University of Texas System (US) 2008-08-20 — — EP disclosed
WO-2007062399-A2 ONCOGENIC RAS-SPECIFIC CYTOTOXIC COMPOUND AND METHODS OF USE THEREOF THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2007-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230114220-A1 COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH PC, FH, SLC25A1 ALDH1A1 544/4885SMN1; SMN2 4322/4885HTT 1660/4885
US-11472804-B2 Compositions and methods for modulating hair growth PC, FH, SLC25A1 ALDH1A1 544/4885SMN1; SMN2 4322/4885HTT 1660/4885
US-20250304579-A1 COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH PC, FH, SLC25A1 ALDH1A1 544/4885SMN1; SMN2 4322/4885HTT 1660/4885
US-11787804-B2 Compositions and methods for modulating hair growth PC, FH, SLC25A1 ALDH1A1 544/4885SMN1; SMN2 4322/4885HTT 1660/4885
US-20240025895-A1 COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH PC, FH, SLC25A1 ALDH1A1 544/4885SMN1; SMN2 4322/4885HTT 1660/4885
US-20090286847-A1 ONCOGENIC RAS-SPECIFIC CYTOTOXIC COMPOUND AND METHODS OF USE THEREOF KRAS, NRAS, HRAS ALDH1A1 790/4885SMN1; SMN2 4170/4885HTT 3011/4885
US-12227503-B2 Compositions and methods for modulating hair growth PC, FH, SLC25A1 ALDH1A1 544/4885SMN1; SMN2 4322/4885HTT 1660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback